IL87662A0 - Pharmaceutical compositions containing 2-alkoxy-n-(1-azabi-cyclo(2.2.2)oct-3-yl)-benzamides and thiobenzamides - Google Patents

Pharmaceutical compositions containing 2-alkoxy-n-(1-azabi-cyclo(2.2.2)oct-3-yl)-benzamides and thiobenzamides

Info

Publication number
IL87662A0
IL87662A0 IL87662A IL8766288A IL87662A0 IL 87662 A0 IL87662 A0 IL 87662A0 IL 87662 A IL87662 A IL 87662A IL 8766288 A IL8766288 A IL 8766288A IL 87662 A0 IL87662 A0 IL 87662A0
Authority
IL
Israel
Prior art keywords
alkoxy
thiobenzamides
benzamides
oct
azabi
Prior art date
Application number
IL87662A
Other languages
English (en)
Original Assignee
Naylor Robert John
Brenda Naylor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naylor Robert John, Brenda Naylor filed Critical Naylor Robert John
Publication of IL87662A0 publication Critical patent/IL87662A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL87662A 1987-09-04 1988-09-02 Pharmaceutical compositions containing 2-alkoxy-n-(1-azabi-cyclo(2.2.2)oct-3-yl)-benzamides and thiobenzamides IL87662A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878720805A GB8720805D0 (en) 1987-09-04 1987-09-04 2-alkoxy-n-(1-azabicyclo(2 2 2)oct-3-yl)benzamides & thiobenzamides

Publications (1)

Publication Number Publication Date
IL87662A0 true IL87662A0 (en) 1989-02-28

Family

ID=10623261

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87662A IL87662A0 (en) 1987-09-04 1988-09-02 Pharmaceutical compositions containing 2-alkoxy-n-(1-azabi-cyclo(2.2.2)oct-3-yl)-benzamides and thiobenzamides

Country Status (12)

Country Link
US (1) US4877794A (de)
EP (1) EP0306345B1 (de)
JP (1) JPH0269417A (de)
AT (1) ATE88091T1 (de)
AU (1) AU614768B2 (de)
CA (1) CA1318595C (de)
DE (1) DE3880240T2 (de)
DK (1) DK492688A (de)
GB (1) GB8720805D0 (de)
IL (1) IL87662A0 (de)
PH (1) PH25429A (de)
ZA (1) ZA886586B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3878235T2 (de) * 1988-08-04 1993-06-03 Synthelabo Antischizophren-wirksame s-n-(1-azabicyclo (2.2.2.)oct-3-yl)benzamide und thiobenzamide.
AU631632B2 (en) * 1989-04-21 1992-12-03 Novartis Ag Therapeutic use of 5-ht3 receptor antagonists
US5236931A (en) * 1992-03-26 1993-08-17 A. H. Robins Company, Incorporated 2-substituted benzamide and benzoate derivatives of 3-aminoquinuclidine and 3-quinuclidinol
US6486172B2 (en) 2000-08-18 2002-11-26 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
US6479510B2 (en) 2000-08-18 2002-11-12 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
EP1419162A1 (de) * 2001-08-24 2004-05-19 Pharmacia & Upjohn Company Substituierte aryl-7-aza 2,2,1 bicycloheptane zur behandlung von krankheiten
US6852716B2 (en) 2002-02-15 2005-02-08 Pfizer Inc Substituted-aryl compounds for treatment of disease
CA2475773A1 (en) * 2002-02-20 2003-09-04 Pharmacia & Upjohn Company Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
FR2861076B1 (fr) * 2003-10-17 2006-01-06 Sanofi Synthelabo Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique
EP2344636B1 (de) 2008-10-09 2017-12-06 Howard Hughes Medical Institute Neue chimäre ligandgesteuerte ionenkanäle und anwendungsverfahren dafür

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI763021A7 (de) * 1975-11-03 1977-05-04 Thomae Gmbh Dr K
FI74707C (fi) * 1982-06-29 1988-03-10 Sandoz Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
FR2529548A1 (fr) * 1982-07-02 1984-01-06 Delalande Sa Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique
US4593034A (en) * 1984-04-06 1986-06-03 A. H. Robins Company, Inc. 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
DE201165T1 (de) * 1985-03-14 1989-04-20 Beecham Group P.L.C., Brentford Arzneimittel zur behandlung von emesis, anxietas und "irritable bowel syndrome".
GB8511988D0 (en) * 1985-05-11 1985-06-19 Beecham Group Plc Compounds
ES2051753T3 (es) * 1986-12-16 1994-07-01 Robins Co Inc A H N-(1-azabiciclo(2.2.2)octo-3-il) benzamidas y tiobenzamidas ansioliticas.

Also Published As

Publication number Publication date
DK492688A (da) 1989-03-05
ZA886586B (en) 1990-05-30
DE3880240D1 (de) 1993-05-19
AU2183488A (en) 1989-03-09
ATE88091T1 (de) 1993-04-15
JPH0269417A (ja) 1990-03-08
PH25429A (en) 1991-07-01
EP0306345A2 (de) 1989-03-08
AU614768B2 (en) 1991-09-12
DK492688D0 (da) 1988-09-05
EP0306345B1 (de) 1993-04-14
CA1318595C (en) 1993-06-01
GB8720805D0 (en) 1987-10-14
DE3880240T2 (de) 1993-10-28
EP0306345A3 (en) 1989-06-14
US4877794A (en) 1989-10-31

Similar Documents

Publication Publication Date Title
PH21365A (en) 2-alkoxy-n-(1-azabicyclo(2.2.2) oct -3-yl) benzamides and thiobenzamides
SG120493G (en) N-tert-Butyl-decahydro-2(3-amino-2-hydroxy-4-phenyl-butyl) isoquinoline-3-carboxamide and asparaginyl derivatives thereof
EP0262399A3 (en) Cyclic enol derivatives, production and use thereof
ZA895842B (en) Antischizophrenic-s-n-(1-azabicyclo(2.2.2)oct-3-yl)benzamides and thiobenzamides
IL87662A0 (en) Pharmaceutical compositions containing 2-alkoxy-n-(1-azabi-cyclo(2.2.2)oct-3-yl)-benzamides and thiobenzamides
UA39101C2 (uk) ПОХІДНІ 11<font face="Symbol">b</font>-БЕНЗАЛЬДОКСИМ-ЕСТРА-4,9-ДІЄНУ, СПОСІБ ЇХ ОДЕРЖАННЯ І ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З АНТИПРОГЕСТИНОВОЮ АКТИВНІСТЮ
GB8823605D0 (en) Therapeutic agents
IE893956L (en) Novel compounds
NZ225659A (en) Pharmaceutical compositions containing pyrrolidin-1-yl-6-fluoro-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid derivatives
EP0263506A3 (en) Anticonvulsant composition containing amino acid derivative and use of said amino acid derivative
GB8608893D0 (en) D-nor-7-ergoline derivatives
CA2154485A1 (en) Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders
DE3885978D1 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung.
PH20948A (en) 2,5-pyrrolidindione derivatives useful as antiarrhythmic agents